Sahin, Ugur
Derhovanessian, Evelyna
Miller, Matthias
Kloke, Björn-Philipp
Simon, Petra
Löwer, Martin
Bukur, Valesca
Tadmor, Arbel D.
Luxemburger, Ulrich
Schrörs, Barbara
Omokoko, Tana
Vormehr, Mathias
Albrecht, Christian
Paruzynski, Anna
Kuhn, Andreas N.
Buck, Janina
Heesch, Sandra
Schreeb, Katharina H.
Müller, Felicitas
Ortseifer, Inga
Vogler, Isabel
Godehardt, Eva
Attig, Sebastian
Rae, Richard
Breitkreuz, Andrea
Tolliver, Claudia
Suchan, Martin
Martic, Goran
Hohberger, Alexander
Sorn, Patrick
Diekmann, Jan
Ciesla, Janko
Waksmann, Olga
Brück, Alexandra-Kemmer
Witt, Meike
Zillgen, Martina
Rothermel, Andree
Kasemann, Barbara
Langer, David
Bolte, Stefanie
Diken, Mustafa
Kreiter, Sebastian
Nemecek, Romina
Gebhardt, Christoffer
Grabbe, Stephan
Höller, Christoph
Utikal, Jochen
Huber, Christoph
Loquai, Carmen
Türeci, Özlem
Article History
Received: 30 January 2017
Accepted: 6 June 2017
First Online: 5 July 2017
Competing interests
: Some of the authors are employees at BioNTech AG (Mainz, Germany) as mentioned in the affiliations. U.S. is stock owner of BioNTech AG (Mainz, Germany). U.S., M.L., B.S., M.V., A.N.K., M.D., A.T., Ö.T. and S.K. are inventors on patents and patent applications, which cover parts of this article.